Provenance Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$188K Buy
519
+19
+4% +$6.5K 0.02% 142
2026
Q1
$176K Hold
500
0.02% 128
2025
Q4
$164K Hold
500
0.02% 124
2025
Q3
$141K Hold
500
0.02% 144
2025
Q2
$140K Sell
500
-550
-52% -$156K 0.02% 144
2025
Q1
$327K Sell
1,050
-2,414
-70% -$713K 0.05% 95
2024
Q4
$903K Buy
3,464
+2,956
+582% +$877K 0.12% 56
2024
Q3
$164K Hold
508
0.02% 161
2024
Q2
$159K Hold
508
0.02% 149
2024
Q1
$144K Hold
508
0.02% 163
2023
Q4
$146K Hold
508
0.02% 144
2023
Q3
$137K Buy
+508
New +$127K 0.02% 135

Other funds holding AMGN

Provenance Wealth Advisors's AMGN Position: Q2 2026 in Review

Provenance Wealth Advisors increased its Amgen (AMGN) stake by 3.8% in Q2 2026, buying an estimated $6.5K and bringing the position to 519 shares worth $188K. The position accounts for 0.02% of the portfolio, ranked #142.

Provenance Wealth Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $903K in Q4 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Provenance Wealth Advisors held 519 shares of Amgen worth $188K as of Q2 2026.
  • Provenance Wealth Advisors bought 19 Amgen shares in Q2 2026, an estimated $6.5K.
  • Amgen made up 0.02% of Provenance Wealth Advisors's portfolio in Q2 2026, its #142 holding.
  • Provenance Wealth Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • Provenance Wealth Advisors's Amgen position peaked at $903K in Q4 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.